Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Glaxosmithkline Plc (GSK)

2014-04-18@09:50:39 ET
GSK and Genmab's sBLA for CLL drug receives FDA approval (DTM)

2014-04-18@09:50:18 ET
GlaxoSmithKline receives market authorization for COPD drug in Canada (DTM)

2014-04-18@07:10:53 ET
Glaxo Looking into Misconduct Charges (ZAX)

2014-04-18@04:31:41 ET
GlaxoSmithKline Pharma declines on reporting 43% fall in Q1 net profit (ABW)

2014-04-18@04:18:06 ET
GlaxoSmithKline Pharma reports 43% fall in Q1 net profit (ABW)

2014-04-17@17:24:00 ET

2014-04-17@14:26:55 ET
Glaxo's Tanzeum Approved in the U.S. (ZAX)

2014-04-17@13:04:00 ET
GSK announces approval in Canada for Incruse(TM) Ellipta(TM) (umeclidinium) as a treatment for COPD (CNW)

2014-04-17@08:43:35 ET
GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Resistance At $53.09 (FBM)

2014-04-17@07:31:13 ET
Global Perennial Allergic Rhinitis Pipeline Review 2014 - Analysis of 10 Company Profiles & 12 Drug Profiles (MTO)

2014-04-17@06:33:11 ET
Global Hormone-Sensitive Prostate Cancer Global Clinical Trials Review 2014 - Profiles of 16 Top Organisations (MTO)

2014-04-16@13:31:27 ET
GlaxoSmithKline PLC (GSK) Showing Bearish Technicals (FBM)

2014-04-16@06:37:55 ET
GSK faces criminal bribery investigation in Poland (ABW)

2014-04-16@06:05:29 ET
Global Therapeutic Vaccines Market 2014-2018 with Agenus, Bavarian Nordic A/S, Dendreon, GSK & Novartis International Dominating (MTO)

2014-04-16@05:23:35 ET
GlaxoSmithKline receives FDA approval for diabetes drug (DTM)

2014-04-16@05:23:24 ET
Prosonix enters into licensing agreement with Mylan (DTM)

2014-04-16@04:58:45 ET
Latin America OTC Pharmaceuticals Market 2014-2018 with Bayer HealthCare AG., EMS S.A., Hypermarcas S.A., and Novartis AG Dominating (MTO)

2014-04-16@04:39:29 ET
Prosonix partners with Mylan for global development and commercialisation of generic inhaled respiratory products (MTO)

2014-04-15@21:05:17 ET
GlaxoSmithKline plcCorporate Event Announcement Notice (WSH)

2014-04-15@14:26:00 ET
GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum(TM) (albiglutide) (PRN)